Jason O'Byrne

Chief Financial Officer, principal financial officer and principal accounting officer, Olema Pharmaceuticals, Inc.

In the seat. First published here October 28, 2026; built from records as of October 28, 2026.

Jason O'Byrne has been Chief Financial Officer, principal financial officer and principal accounting officer of Olema Pharmaceuticals, Inc. since August 11, 2026, according to the company's filing of August 13, 2026.¹

The filing gives Jason O'Byrne's previous role as Executive Vice President and Chief Financial Officer at Vir Biotechnology, Inc.¹ Jason O'Byrne joined from outside Olema Pharmaceuticals, Inc., by the record's reading of the filing.¹ The filing shows an earlier chief financial officer seat, so this is not Jason O'Byrne's first.¹

Seats

The seat in the record

Company	Title as filed	Standing	Filings
Olema Pharmaceuticals, Inc. (OLMA) Pharmaceutical Preparations	Chief Financial Officer, principal financial officer and principal accounting officer	In the seat	1

Company names link to the company's page in the record at CFO Tribune, which holds the seat history.

The record

Filing by filing, latest first

August 11, 2026effective
Olema Pharmaceuticals, Inc. appointed Jason O'Byrne as Chief Financial Officer, principal financial officer and principal accounting officer, effective August 11, 2026.
[1] Filing by Olema Pharmaceuticals, Inc., filed with the SEC on August 13, 2026. Read the filing. The record at CFO Tribune.

Sources

Current report filed with the SEC, Olema Pharmaceuticals, Inc.. U.S. Securities and Exchange Commission, EDGAR, filed August 13, 2026. sec.gov; record.

Corrections and removal

If a line here is wrong, or Jason O'Byrne wants this profile taken down, write to corrections@cfospotlights.com. Corrections are made on the page with a dated note; removal requests are answered within 72 hours. The underlying filings stay public at the SEC.